Flucytosine (5FC) placebo pill
Phase 3
Flucytosine (5FC) placebo pill is one of 4 therapeutic programs targeting Talaromycosis. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
4 competitors in Talaromycosis
#DrugCompanyPhaseTrials
1Liposomal Lurtotecan
GileadPhase 3
Ancobon
BBausch Health Americas, Inc.
Phase 3
Flucytosine (5FC) placebo pill
DDuke University
Phase 3
Liposomal Amphotericin B
SSichuan Provincial People's Hospital
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 3[1]
- Company
- DDuke University